HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”, the “Company” or “we”) ...

TAZVERIK ® is a registered trademark of Epizyme Inc., an Ipsen company.

DelveInsight's "CABLIVI Market Size, Forecast, and Market Insight Report" highlights the details around CABLIVI, a von ...

Coalition of Concerned Manufacturers and Businesses of Canada logo (CNW Group/Coalition of Concerned Manufacturers and Businesses of Canada) The CCMBC was formed in 2016 with a mandate to advocate ...

SiriusXM logo (CNW Group/Sirius XM Canada Inc.) Our daily must-listen program, bringing you the very best conversations, interviews, and commentary from across SiriusXM. It's your action-packed ...

including clients' licensing logos, trade names, and trademarks representation. The Sports Data & Technology segment delivers live streaming and data feeds for sports events to sportsbooks ...

NORWALK, Conn., March 10, 2025 (GLOBE NEWSWIRE) -- FactSet (NYSE: FDS) (NASDAQ: FDS), a global financial digital platform and enterprise solutions provider, today announced an adjustment to the time ...

Developed by Sanofi, CABLIVI is the first FDA-approved nanobody therapy for this condition. Increasing awareness, improved diagnostic rates, and rising demand for targeted therapies in hematology ...

Other drugmakers have been looking at Met as a target in cancer, including Novartis, Merck KGaA and Hutchmed, which have all bagged regulatory approvals for oral therapies that target NSCLC ...

SEC Filings provided by EDGAR Online, Inc.

Copyright © 2025 MarketWatch, Inc. All rights reserved.